TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

Alex Angst, CKA, CFP, financial advisor and founder of wealth management company RISE Capital, witnessed this dysfunction ...